This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Module 4: Cardiometabolic Risk in Diabetes
References
- ADA Standards of Medical Care in Diabetes 2011; DIAD study JAMA 2009;301:1547-1555
- Adapted from Haffner SM, et al. N Engl J Med. 1998;339:229–234
- Ross, NEJM 1999;340:115-126
- Cholesterol Treatment Trialists’ (CTT) Collaborators. Lancet. 2005;366:1267-1278
- Meta-analysis: Statin Therapy Does Not Alter the Association Between Low Levels of High-Density Lipoprotein Cholesterol and Increased Cardiovascular Risk, Ann Intern Med. 2010;153:800-808
- Adapted from Barter et al, NEJM 2007, 357; 13, 1301-1310
- Adapted from Prove IT-TIMI 22-Miller M, et al. J Am Coll Cardiol. 2008;51:724–730.
- Adapted from Rubins HB et al. N Engl.J Med. 1999;341:410-418
- Goldberg A et al. Am J Cardiol 2000;85:1100-1105
- Coronary Drug Project Research Group. JAMA 1975;231:360-381
- Adapted from Brown BG et al. N Engl J Med 2001;345:1583-1592
- Adapted from Report of the National Lipid Association’s Safety Task Force: Am J Cardiol 2007;99(suppl):3C-18C
- Adapted from Report of the National Lipid Association’s Safety Task Force: Am J Cardiol 2007;99(suppl):3C-18C
- Adapted from Mozaffarian, D. et al. JAMA 2006;296:1885-1899
- Adapted from Gaede P, et al. N Engl J Med. 2008;358:580–591
- Adapted from Am J. Cardiol 2006;98:1231-33
- Adapted from Table 2 US analysis of Stellar trial Am J Cardiol 2005;95:360–366
- JAMA 285(19):2486-2497 & 2004 addendum
- Adapted from Liu J, et al. Am J Cardiol. 2006;98:1363-1368
- Adapted from Diabetes Care June 2010 1389-94
- UKPDS 10 year study NEJM 2008;359:1-10
- DCCT-EDIC NEJM 2005;353:2643-53
- Adapted from UKPDS 10 year study NEJM 2008;359:1-10
- ADA standards of Diabetes Care 2010—found online at www.diabetes.org
- Stuveling EM, Bakker SJ, Hillege HL, Burgerhof JG, de Jong PE, Gans RO, de Zeeuw D. C-reactive protein modifies the relationship between blood pressure and microalbuminuria. Hypertension. 2004;43:791–796
- Clausen et al Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: a 4-year prospective study. Clin Sci (Lond). 1999;97:37– 43
- Targher G et al. N Engl J Med 2010;363:1341-1350
- Chalasani N (2005), Hepatology 41(4):690-695
- Rallidis LS et al. (2004), Atherosclerosis 174(1):193-196
- McKenney JM et al. (2006), Am J Cardiol 97(8A):89C-94C
- National Lipid Association’s Safety Task Force: Am J Cardiol 2007;99(suppl):3C-18C
- Adapted from Table 2 Blood Pressure and CV risk in the VADT trial-Diabetes Care 2011;34:34-38
- 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk Circulation 2010;122;2748-2764
- Cromwell Am J Cardiol. 2006 Dec 15;98(12):1599-602 Framingham Offspring Study participants with metabolic syndrome(2993)Circulation 2006;113;20-29
- Journal of Clinical Lipidology 2008; 2: 410–417
- Framingham Offspring Study participants with metabolic syndrome (2993) Circulation 2006;113;20-29
- Insulin resistance associated with ↓ LDL size, Insulin Resistance Atherosclerosis Study. Metabolism. 2005;54:264 –270
- Journal of Clinical Lipidology 2008; 2: 410–417
- von Eckardstein A, et al. Lipoprotein (a) further increases the risk of coronary events in men with high global cardiovascular risk. J Am Coll Cardiol.2004;37:434–439
- 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk Circulation 2010;122;2748-2764
- Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes Ann Intern Med. 2009;150:474-484
- 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk Circulation 2010;122;2748-2764
- Shea Improving Medication Adherence-how to talk to patients about their medications Lippincott Willams &Wilkins 2006 Philadelphia
- The Adherence Estimator: a screening tool to estimate propensity to adhere to prescription medications for chronic disease Current Research and Opinions 2009;25:215-238
- Adapted from Diabetes Care 2010;33:1200–1205
References
Module 1: Assessment and Diagnosis of Diabetes
Module 2: Diabetes Treatment and Interventions
Module 3: Pharmacologic Management of Diabetes
Module 4: Cardiometabolic Risk in Diabetes
Module 5: Hypertension and Microvascular Disease in Diabetes
Module 6: Other Populations, Special Situations, and Complications